Literature DB >> 17928005

Cerebrospinal fluid cytokine responses in human eosinophilic meningitis associated with angiostrongyliasis.

Pewpan M Intapan1, Suvicha Kittimongkolma, Kanigar Niwattayakul, Kittisak Sawanyawisuth, Wanchai Maleewong.   

Abstract

The levels of interleukin 5 (IL5), IL10, and IL13 in the cerebrospinal fluid (CSF) were markedly higher in 30 patients with eosinophilic meningitis associated with angiostrongyliasis (EOMA) than in the controls (P<0.001). IL2, IL4, interferon gamma (IFNgamma), and tumor necrosis factor alpha (TNFalpha) levels were not significantly different (P>0.05). IL5, IL10, and TNFalpha levels correlated with eosinophil levels (P=0.023, P=0.018, and P=0.005, respectively) while IL2, IL4, IL13, and IFNgamma did not (P>0.05). Our data suggest that local T-helper-2 (TH2) cytokine responses are predominant in the CSF of patients with EOMA. Data on T lymphocyte-parasite interactions are important for the design of effective vaccines and immunotherapies. The measurement of T-helper-1 (TH1)/TH2 cytokines in the CSF may also have some potential for the diagnosis of parasite associated meningitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17928005     DOI: 10.1016/j.jns.2007.09.023

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

1.  Spleen atrophy related immune system changes attributed to infection of Angiostrongylus cantonensis in mouse model.

Authors:  Zhen Liu; Yu Wu; Ying Feng; Feng Wu; Rui-Feng Liu; Li-Fu Wang; Jin-Yi Liang; Jia-Hua Liu; Xi Sun; Zhong-Dao Wu
Journal:  Parasitol Res       Date:  2016-11-22       Impact factor: 2.289

2.  Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL).

Authors:  Takashi Sasayama; Satoshi Nakamizo; Masamitsu Nishihara; Atsufumi Kawamura; Hirotomo Tanaka; Katsu Mizukawa; Shigeru Miyake; Masaaki Taniguchi; Kohkichi Hosoda; Eiji Kohmura
Journal:  Neuro Oncol       Date:  2011-12-12       Impact factor: 12.300

3.  Differences in microglia activation between rats-derived cell and mice-derived cell after stimulating by soluble antigen of IV larva from Angiostrongylus cantonensis in vitro.

Authors:  Jie Wei; Feng Wu; Xi Sun; Xin Zeng; Jin-Yi Liang; Huan-Qin Zheng; Xin-Bing Yu; Kou-Xing Zhang; Zhong-Dao Wu
Journal:  Parasitol Res       Date:  2012-10-17       Impact factor: 2.289

Review 4.  Granulocytes in helminth infection -- who is calling the shots?

Authors:  B L Makepeace; C Martin; J D Turner; S Specht
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

5.  Interface Molecules of Angiostrongylus cantonensis: Their Role in Parasite Survival and Modulation of Host Defenses.

Authors:  Alessandra L Morassutti; Carlos Graeff-Teixeira
Journal:  Int J Inflam       Date:  2012-03-26

6.  Preliminary expression profile of cytokines in brain tissue of BALB/c mice with Angiostrongylus cantonensis infection.

Authors:  Liping Yu; Xiaoying Wu; Jie Wei; Qi Liao; Lian Xu; Siqi Luo; Xin Zeng; Yi Zhao; Zhiyue Lv; Zhongdao Wu
Journal:  Parasit Vectors       Date:  2015-06-14       Impact factor: 3.876

7.  Anti-apoptotic effects of Sonic hedgehog signalling through oxidative stress reduction in astrocytes co-cultured with excretory-secretory products of larval Angiostrongylus cantonensis.

Authors:  Kuang-Yao Chen; Cheng-Hsun Chiu; Lian-Chen Wang
Journal:  Sci Rep       Date:  2017-02-07       Impact factor: 4.379

8.  Trichostatin A, a Histone Deacetylase Inhibitor, Alleviates Eosinophilic Meningitis Induced by Angiostrongylus cantonensis Infection in Mice.

Authors:  Yanhua Zhang; Hui Xie; Wenyan Tang; Xingda Zeng; Yu Lin; Lian Xu; Lihua Xiao; Jun Xu; Zhongdao Wu; Dongjuan Yuan
Journal:  Front Microbiol       Date:  2019-10-04       Impact factor: 5.640

9.  Larva Migration and Eosinophilia in Mice Experimentally Infected With Gnathostoma spinigerum.

Authors:  W Saksirisampant; N Choomchuay; K Kraivichian; B Wongsatayanon Thanomsub
Journal:  Iran J Parasitol       Date:  2012       Impact factor: 1.012

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.